Taking the Next Steps With Next-Generation BTKi in CLL, MCL, and DLBCL 

Chair, John C. Byrd, MD, and Kami Maddocks, MD, discuss B-cell cancers in this CME/MOC activity titled “Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL.” For the full presentation, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/EVF865. CME/MOC credit will be available until February 1, 2024.